RE: Takeover/Merger27 Jan 2022 09:35
Paraytec's corporate finance adviser has engaged with over 70 companies from a wide spectrum of global markets. Meetings are ongoing with potential partners for licensing and/or co-development of the technology, some of which are potential acquirers of the company. In these discussions, it is clear that potential partners believe a low cost, rapid and accurate test for COVID-19 will be needed for many years to come. They also like the fact that Paraytec's technology can be potentially used as a platform for other diseases and cancer detection
My son and I really like this paragraph"""" Paraytec's technology can be potentially used as a platform for other diseases and cancer detection""""
Gla